nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced lipoxidation end-products
|
Pamplona, Reinald |
|
2011 |
192 |
1-2 |
p. 14-20 7 p. |
artikel |
2 |
An integrated reactive metabolite evaluation approach to assess and reduce safety risk during drug discovery and development
|
Reese, Melinda |
|
2011 |
192 |
1-2 |
p. 60-64 5 p. |
artikel |
3 |
Benzene, the exposome and future investigations of leukemia etiology
|
Smith, Martyn T. |
|
2011 |
192 |
1-2 |
p. 155-159 5 p. |
artikel |
4 |
Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function
|
Ross, David |
|
2011 |
192 |
1-2 |
p. 145-149 5 p. |
artikel |
5 |
Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases
|
Nishida, Clinton R. |
|
2011 |
192 |
1-2 |
p. 21-25 5 p. |
artikel |
6 |
Biological reactive intermediates (BRIs) formed from botanical dietary supplements
|
Dietz, Birgit M. |
|
2011 |
192 |
1-2 |
p. 72-80 9 p. |
artikel |
7 |
1,3-Butadiene: Biomarkers and application to risk assessment
|
Swenberg, James A. |
|
2011 |
192 |
1-2 |
p. 150-154 5 p. |
artikel |
8 |
Contents
|
|
|
2011 |
192 |
1-2 |
p. v-vi nvt p. |
artikel |
9 |
Contribution of denaturing and deodorization processes of oils to toxic oil syndrome
|
Ruiz-Méndez, M. Victoria |
|
2011 |
192 |
1-2 |
p. 142-144 3 p. |
artikel |
10 |
Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease
|
Jinsmaa, Yunden |
|
2011 |
192 |
1-2 |
p. 118-121 4 p. |
artikel |
11 |
Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity
|
Park, B.K. |
|
2011 |
192 |
1-2 |
p. 30-36 7 p. |
artikel |
12 |
Editorial Board
|
|
|
2011 |
192 |
1-2 |
p. ii- 1 p. |
artikel |
13 |
Editorial Board
|
|
|
2011 |
192 |
1-2 |
p. CO2- 1 p. |
artikel |
14 |
Electrophilic eicosanoids: Signaling and targets
|
Pérez-Sala, Dolores |
|
2011 |
192 |
1-2 |
p. 96-100 5 p. |
artikel |
15 |
Flavonoids and alkenylbenzenes: New concepts in bioactivation studies
|
Rietjens, Ivonne M.C.M. |
|
2011 |
192 |
1-2 |
p. 87-95 9 p. |
artikel |
16 |
Handling reactive metabolite positives in drug discovery: What has retrospective structure–toxicity analyses taught us?
|
Kalgutkar, Amit S. |
|
2011 |
192 |
1-2 |
p. 46-55 10 p. |
artikel |
17 |
Induction of the Keap1/Nrf2/ARE pathway by oxidizable diphenols
|
Dinkova-Kostova, Albena T. |
|
2011 |
192 |
1-2 |
p. 101-106 6 p. |
artikel |
18 |
Introduction to the Proceedings of the 8th International Symposium on Biological Reactive Intermediates
|
Monks, Terrence J. |
|
2011 |
192 |
1-2 |
p. 1-2 2 p. |
artikel |
19 |
1-Methoxy-3-indolylmethyl glucosinolate; a potent genotoxicant in bacterial and mammalian cells: Mechanisms of bioactivation
|
Glatt, Hansruedi |
|
2011 |
192 |
1-2 |
p. 81-86 6 p. |
artikel |
20 |
New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism
|
Kimzey, Michael J. |
|
2011 |
192 |
1-2 |
p. 122-128 7 p. |
artikel |
21 |
Origins of the International Symposium on Biological Reactive Intermediates and some Thoughts on Homeostasis and the Biological Significance of Widespread Covalent Binding of Biological Reactive Metabolites
|
|
|
2011 |
192 |
1-2 |
p. 3-7 5 p. |
artikel |
22 |
Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease
|
Smathers, Rebecca L. |
|
2011 |
192 |
1-2 |
p. 107-112 6 p. |
artikel |
23 |
Overview of strategies for addressing BRIs in drug discovery: Impact on optimization and design
|
Humphreys, W. Griffith |
|
2011 |
192 |
1-2 |
p. 56-59 4 p. |
artikel |
24 |
PAH intermediates: Links between the atmosphere and biological systems
|
Simonich, Staci L. Massey |
|
2011 |
192 |
1-2 |
p. 26-29 4 p. |
artikel |
25 |
Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS)
|
Messeguer, Angel |
|
2011 |
192 |
1-2 |
p. 136-141 6 p. |
artikel |
26 |
Proteomics of toxic oil syndrome in humans: Phenotype distribution in a population of patients
|
Quero, Carmen |
|
2011 |
192 |
1-2 |
p. 129-135 7 p. |
artikel |
27 |
Putting bioactivation reactions to work: Targeting antioxidants to mitochondria
|
Anders, M.W. |
|
2011 |
192 |
1-2 |
p. 8-13 6 p. |
artikel |
28 |
Quantitative mass spectrometry reveals the epigenome as a target of arsenic
|
Chu, Feixia |
|
2011 |
192 |
1-2 |
p. 113-117 5 p. |
artikel |
29 |
Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development
|
Thompson, Richard A. |
|
2011 |
192 |
1-2 |
p. 65-71 7 p. |
artikel |
30 |
The cap’n’collar transcription factor Nrf2 mediates both intrinsic resistance to environmental stressors and an adaptive response elicited by chemopreventive agents that determines susceptibility to electrophilic xenobiotics
|
Higgins, Larry G. |
|
2011 |
192 |
1-2 |
p. 37-45 9 p. |
artikel |